Laboratory of Developmental Biology, Department of Morphology and Genetics, Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil.
Andrology. 2018 Jan;6(1):236-246. doi: 10.1111/andr.12426. Epub 2017 Oct 3.
Doxorubicin has been largely used in anticancer therapy in adults, adolescents, and children. The efficacy of l-carnitine as an antioxidant substance has been confirmed both in humans and rats. Carnitine, present in testis and epididymis, is involved in sperm maturation. It is also effective in infertility treatment. As a continuation of a previous study, we evaluated whether some spermatic qualitative parameters, DNA integrity, chromatin structure, and fertility status, could be ameliorated by the carnitine treatment in adult rats, which were subsequently exposed to doxorubicin at pre-puberty. Pre-pubertal male rats were distributed into four groups: Sham Control; Doxorubicin; l-carnitine; l-carnitine + Doxorubicin (l-carnitine injected 1 h before doxorubicin). At 100 days of age, all groups were reassigned into two sets: One set was submitted to the evaluation of sperm motility, acrosome integrity, mitochondrial activity, sperm chromatin structure analysis (SCSA), and evaluation of the oxidative stress. The other set of rats was destined to the evaluation of reproductive competence. The percentage of spermatozoa with intact acrosome integrity was higher in the Carnitine+Doxorubicin group when compared with the Doxorubicin group. However, sperm motility and mitochondrial activity were not improved by carnitine pre-treatment. Both values of malondialdehyde and nitrite (indirect measurement of nitric oxide) concentrations were statistically higher in the only doxorubicin-treated group when compared to the Carnitine + Doxorubicin group. Fertility index and implantation rate were lower in Doxorubicin group, when compared to Carnitine + Doxorubicin group. Moreover, the percentage of spermatozoa with damaged DNA was higher in the Doxorubicin-treated group when compared to the Carnitine+Doxorubicin group. l-carnitine, when administered before doxorubicin, partially preserved the acrosome integrity, an important feature related to sperm fertilization ability that positively correlated with the reproductive competence and sperm DNA integrity at adulthood. In conclusion, l-carnitine attenuated the long-term alterations caused by doxorubicin in the germ cells and improved male reproductive capacity in adulthood.
多柔比星在成人、青少年和儿童的抗癌治疗中得到了广泛应用。左旋肉碱作为一种抗氧化物质的功效已在人类和大鼠中得到证实。肉碱存在于睾丸和附睾中,参与精子成熟。它在不孕治疗中也很有效。作为之前一项研究的延续,我们评估了在未成年时暴露于多柔比星的成年大鼠中,肉碱治疗是否可以改善一些精子质量参数、DNA 完整性、染色质结构和生育能力。未成年雄性大鼠分为四组:假手术对照;多柔比星;左旋肉碱;左旋肉碱+多柔比星(多柔比星前 1 小时注射左旋肉碱)。在 100 天龄时,所有组均重新分为两组:一组用于评估精子活力、顶体完整性、线粒体活性、精子染色质结构分析(SCSA)和氧化应激评估。另一组大鼠用于评估生殖能力。与多柔比星组相比,左旋肉碱+多柔比星组的完整顶体完整性精子的百分比更高。然而,肉碱预处理并不能改善精子活力和线粒体活性。仅多柔比星处理组的丙二醛和亚硝酸盐(一氧化氮的间接测量值)浓度的两个值均明显高于左旋肉碱+多柔比星组。与左旋肉碱+多柔比星组相比,多柔比星组的生育指数和着床率较低。与左旋肉碱+多柔比星组相比,多柔比星处理组的受损 DNA 精子百分比更高。左旋肉碱在多柔比星之前给药时,部分保留了顶体完整性,这是与精子受精能力相关的重要特征,与成年后的生殖能力和精子 DNA 完整性呈正相关。总之,左旋肉碱减轻了多柔比星对生殖细胞的长期影响,并改善了成年雄性的生殖能力。